LENNON DAVID JAMES (CHIEF EXECUTIVE OFFICER) sold 32.8% of their position (260.43K shares) of WHITEHAWK THERAPEUTICS, INC. on the open market
Open‑market sale worth $899.5K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 4/9/2026ACC: 0001995275-26-000008
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Mar 2026
-260.43K
Net shares
Net seller
$899.5K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
260.43K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−102.39K
Price / share
$3.51
Trade value
$359.41K
% of position
12.9%
4/6/2026
793.55K→691.15K
Common Stock
Direct
Shares
−94.09K
Price / share
$3.43
Trade value
$322.72K
% of position
13.6%
4/7/2026
691.15K→597.07K
Common Stock
Direct
Shares
−63.95K
Price / share
$3.40
Trade value
$217.41K
% of position
10.7%
4/8/2026
597.07K→533.12K
Total
Net shares
−260.43K
Net value
-$899.54K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/6/2026 | S · Sale | −102.39K | $3.51 | $359.41K | 12.9% | 793.55K | 691.15K |
| Common Stock Direct | 4/7/2026 | S · Sale | −94.09K | $3.43 | $322.72K | 13.6% | 691.15K | 597.07K |
| Common Stock Direct | 4/8/2026 | S · Sale | −63.95K | $3.40 | $217.41K | 10.7% | 597.07K | 533.12K |
| Total | −260.43K | -$899.54K | ||||||
Derivative Transactions0
No derivative transactions reported